Australian Pharmaceutical Industries Ltd · Dividends
ASX: API · Health Care · Health Care Distributors
Dividends per share
Per financial year, as reported in the accounts
Payment record
Totals paid and share of profit distributed
| FY | Per share | Total paid | Payout ratio |
|---|---|---|---|
| FY21 | $0.04 | $17.2M | 1,505% |
| FY20 | $0.04 | $19.7M | – |
| FY19 | $0.08 | $38.2M | 67% |
| FY18 | $0.07 | $34.5M | 71% |
| FY17 | $0.07 | $34.3M | 65% |
| FY16 | $0.05 | $24.4M | 47% |
| FY15 | $0.04 | $19.5M | 45% |
| FY14 | $0.03 | $15.9M | – |
| FY13 | $0.03 | $14.6M | 60% |
| FY12 | $0.03 | $14.6M | 48% |
Reading the payout ratio
The payout ratio is the share of net profit returned to shareholders as dividends. A ratio under ~70% generally leaves room to maintain the dividend through a weaker year; a ratio persistently near or above 100% means the company is paying out more than it earns, which is rarely sustainable. Per-share figures here are company-reported annual totals. Check the company's own announcements for franking credits and payment dates.
What was Australian Pharmaceutical Industries' (API) dividend history before it delisted from the ASX?
Australian Pharmaceutical Industries (API) paid a dividend in every year of its reported history, rising from $0.03 per share in FY2012 to a peak of $0.0769 in FY2019, before being cut to $0.04 in FY2020 and $0.035 in FY2021, the final year on record.
The payout ratio against net income was volatile. It ran as high as 71.5% in FY2018 and 67.5% in FY2019 during profitable years, but turned negative in FY2014 (-17.5%) when the company reported a net loss. In the final two years the payout ratio became extreme: -248.3% in FY2020, when a loss was reported alongside a $19.7M dividend, and 1504.6% in FY2021, when just $1.1M of net income was reported against $17.2M paid out in dividends.
This pattern shows dividends being maintained, and even increased in nominal terms across much of the record, largely independent of the swings in underlying earnings, with payouts continuing through loss-making years and a year of near-breakeven profit.
AI-assisted analysis generated from Craytheon's verified financial data · Updated 4 Jul 2026 · How this works
Data is general information only, not financial advice. Figures are as reported in company filings (some ASX companies report in USD); share prices are AUD.